Correction: challenges in developing a validated biomarker for angiogenesis inhibitors: the motesanib experience.
[This corrects the article DOI: 10.1371/journal.pone.0108048.].
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4374716?pdf=render |